Medical Oncology Software Market Size, Share & Industry Impact Analysis, By Deployment Type (Cloud, On-premise, and Hybrid), By Application (Treatment Planning, Patient Record Management, Clinical Decision Support, and Others), By End-user (Hospitals & Specialty Clinics, Diagnostic Centers, Research Institutes, and Others), and Regional Forecast, 2025-2032

Last Updated: March 19, 2025 | Format: PDF | Report ID: FBI108933

Table of Content

Introduction
1. Research Scope
2. Market Segmentation
3. Research Methodology
4. Definitions and Assumptions

Introduction
1. Research Scope
2. Market Segmentation
3. Research Methodology
4. Definitions and Assumptions
Executive Summary
Market Dynamics
1. Market Drivers
2. Market Restraints
3. Market Opportunities
4. Market Trends
Key Insights
1. Prevalence of Cancer, by Key Countries, in 2023/2024
2. Recent Technological Advancements in Medical Oncology Software
3. New Product Launches by Market Players
4. Key Industry Developments - Mergers, Acquisitions, Partnerships
5. Impact of COVID-19 on the Market
Global Medical Oncology Software Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Deployment Type
  1. Clouds
  2. On-premise
  3. Hybrid
2. Market Analysis, Insights and Forecast – By Application
  1. Treatment Planning
  2. Patient Record Management
  3. Clinical Decision Support
  4. Others
3. Market Analysis, Insights and Forecast – By End User
  1. Hospitals & Specialty Clinics
  2. Diagnostic Centers
  3. Research Institutes
  4. Others
4. Market Analysis, Insights and Forecast – By Region
  1. North America
  2. Europe
  3. Asia Pacific
  4. Latin America
  5. Middle East & Africa
North America Medical Oncology Software Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Deployment Type
  1. Clouds
  2. On-premise
  3. Hybrid
2. Market Analysis, Insights and Forecast – By Application
  1. Treatment Planning
  2. Patient Record Management
  3. Clinical Decision Support
  4. Others
3. Market Analysis, Insights and Forecast – By End User
  1. Hospitals & Specialty Clinics
  2. Diagnostic Centers
  3. Research Institutes
  4. Others
4. Market Analysis, Insights and Forecast – By Country
  1. U.S.
  2. Canada
Europe Medical Oncology Software Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Deployment Type
  1. Clouds
  2. On-premise
  3. Hybrid
2. Market Analysis, Insights and Forecast – By Application
  1. Treatment Planning
  2. Patient Record Management
  3. Clinical Decision Support
  4. Others
3. Market Analysis, Insights and Forecast – By End User
  1. Hospitals & Specialty Clinics
  2. Diagnostic Centers
  3. Research Institutes
  4. Others
4. Market Analysis, Insights and Forecast – By Country/ Sub-Region
  1. Germany
  2. U.K.
  3. France
  4. Italy
  5. Spain
  6. Scandinavia
  7. Rest of Europe
Asia Pacific Medical Oncology Software Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Deployment Type
  1. Clouds
  2. On-premise
  3. Hybrid
2. Market Analysis, Insights and Forecast – By Application
  1. Treatment Planning
  2. Patient Record Management
  3. Clinical Decision Support
  4. Others
3. Market Analysis, Insights and Forecast – By End User
  1. Hospitals & Specialty Clinics
  2. Diagnostic Centers
  3. Research Institutes
  4. Others
4. Market Analysis, Insights and Forecast – By Country/ Sub-Region
  1. China
  2. Japan
  3. India
  4. Australia
  5. Southeast Asia
  6. Rest of Asia Pacific
Latin America Medical Oncology Software Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Deployment Type
  1. Clouds
  2. On-premise
  3. Hybrid
2. Market Analysis, Insights and Forecast – By Application
  1. Treatment Planning
  2. Patient Record Management
  3. Clinical Decision Support
  4. Others
3. Market Analysis, Insights and Forecast – By End User
  1. Hospitals & Specialty Clinics
  2. Diagnostic Centers
  3. Research Institutes
  4. Others
4. Market Analysis, Insights and Forecast – By Country/ Sub-Region
  1. Brazil
  2. Mexico
  3. Rest of Latin America
Middle East & Africa Medical Oncology Software Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Deployment Type
  1. Clouds
  2. On-premise
  3. Hybrid
2. Market Analysis, Insights and Forecast – By Application
  1. Treatment Planning
  2. Patient Record Management
  3. Clinical Decision Support
  4. Others
3. Market Analysis, Insights and Forecast – By End User
  1. Hospitals & Specialty Clinics
  2. Diagnostic Centers
  3. Research Institutes
  4. Others
4. Market Analysis, Insights and Forecast – By Country/ Sub-Region
  1. GCC
  2. South Africa
  3. Rest of Middle East & Africa
Competitive Analysis
1. Global Market Share Analysis (2024)
2. Company Profiles
  1. Epic Systems Corporation
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  2. Altai, Inc.
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  3. Varian Medical Systems, Inc. (Siemens Healthineers AG)
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  4. Cerner Corporation (Oracle)
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  5. American Medical Software
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  6. Elekta
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  7. EndoSoft LLC
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  8. RaySearch Laboratories
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  9. MCKESSON CORPORATION
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  10. Koninklijke Philips N.V.
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)

Read Less

List of Figures

Figure 01: Global Medical Oncology Software Market Revenue Breakdown (USD billion, %) by Region, 2024 & 2032

Figure 02: Global Medical Oncology Software Market Value Share (%), By Deployment Type, 2024 & 2032

Figure 03: Global Medical Oncology Software Market Value Share (%), By Application, 2024 & 2032

Figure 04: Global Medical Oncology Software Market Value Share (%), By End User, 2024 & 2032

Figure 05: Global Medical Oncology Software Market Value Share (%), By Region, 2024 & 2032

Figure 06: North America Medical Oncology Software Market Value (USD billion), by Deployment Type, 2024 & 2032

Figure 07: North America Medical Oncology Software Market Value Share (%), by Deployment Type, 2024

Figure 08: North America Medical Oncology Software Market Value (USD billion), by Application, 2024 & 2032

Figure 09: North America Medical Oncology Software Market Value Share (%), by Application, 2024

Figure 10: North America Medical Oncology Software Market Value (USD billion), by End User, 2024 & 2032

Figure 11: North America Medical Oncology Software Market Value Share (%), by End User, 2024

Figure 12: North America Medical Oncology Software Market Value (USD billion), by Country, 2024 & 2032

Figure 13: North America Medical Oncology Software Market Value Share (%), by Country, 2024

Figure 14: Europe Medical Oncology Software Market Value (USD billion), by Deployment Type, 2024 & 2032

Figure 15: Europe Medical Oncology Software Market Value Share (%), by Deployment Type, 2024

Figure 16: Europe Medical Oncology Software Market Value (USD billion), by Application, 2024 & 2032

Figure 17: Europe Medical Oncology Software Market Value Share (%), by Application, 2024

Figure 18: Europe Medical Oncology Software Market Value (USD billion), by End User, 2024 & 2032

Figure 19: Europe Medical Oncology Software Market Value Share (%), by End User, 2024

Figure 20: Europe Medical Oncology Software Market Value (USD billion), by Country/Sub-Region, 2024 & 2032

Figure 21: Europe Medical Oncology Software Market Value Share (%), by Country/Sub-Region, 2024

Figure 22: Asia Pacific Medical Oncology Software Market Value (USD billion), by Deployment Type, 2024 & 2032

Figure 23: Asia Pacific Medical Oncology Software Market Value Share (%), by Deployment Type, 2024

Figure 24: Asia Pacific Medical Oncology Software Market Value (USD billion), by Application, 2024 & 2032

Figure 25: Asia Pacific Medical Oncology Software Market Value Share (%), by Application, 2024

Figure 26: Asia Pacific Medical Oncology Software Market Value (USD billion), by End User, 2024 & 2032

Figure 27: Asia Pacific Medical Oncology Software Market Value Share (%), by End User, 2024

Figure 28: Asia Pacific Medical Oncology Software Market Value (USD billion), by Country/Sub-Region, 2024 & 2032

Figure 29: Asia Pacific Medical Oncology Software Market Value Share (%), by Country/Sub-Region, 2024

Figure 30: Latin America Medical Oncology Software Market Value (USD billion), by Deployment Type, 2024 & 2032

Figure 31: Latin America Medical Oncology Software Market Value Share (%), by Deployment Type, 2024

Figure 32: Latin America Medical Oncology Software Market Value (USD billion), by Application, 2024 & 2032

Figure 33: Latin America Medical Oncology Software Market Value Share (%), by Application, 2024

Figure 34: Latin America Medical Oncology Software Market Value (USD billion), by End User, 2024 & 2032

Figure 35: Latin America Medical Oncology Software Market Value Share (%), by End User, 2024

Figure 36: Latin America Medical Oncology Software Market Value (USD billion), by Country, 2024 & 2032

Figure 37: Latin America Medical Oncology Software Market Value Share (%), by Country, 2024

Figure 38: Middle East & Africa Medical Oncology Software Market Value (USD billion), by Deployment Type, 2024 & 2032

Figure 39: Middle East & Africa Medical Oncology Software Market Value Share (%), by Deployment Type, 2024

Figure 40: Middle East & Africa Medical Oncology Software Market Value (USD billion), by Application, 2024 & 2032

Figure 41: Middle East & Africa Medical Oncology Software Market Value Share (%), by Application, 2024

Figure 42: Middle East & Africa Medical Oncology Software Market Value (USD billion), by End User, 2024 & 2032

Figure 43: Middle East & Africa Medical Oncology Software Market Value Share (%), by End User, 2024

Figure 44: Middle East & Africa Medical Oncology Software Market Value (USD billion), by Country, 2024 & 2032

Figure 45: Middle East & Africa Medical Oncology Software Market Value Share (%), by Country, 2024

Figure 46: Global Medical Oncology Software Market Share Analysis, By Company, 2024

List of Tables

Table 01: Global Medical Oncology Software Market Revenue (USD billion) Forecast, By Deployment Type, 2019–2032

Table 02: Global Medical Oncology Software Market Revenue (USD billion) Forecast, By Application, 2019–2032

Table 03: Global Medical Oncology Software Market Revenue (USD billion) Forecast, By End User, 2019–2032

Table 04: Global Medical Oncology Software Market Revenue (USD billion) Forecast, By Region, 2019–2032

Table 05: North America Medical Oncology Software Market Revenue (USD billion) Forecast, By Deployment Type, 2019–2032

Table 06: North America Medical Oncology Software Market Revenue (USD billion) Forecast, By Application, 2019–2032

Table 07: North America Medical Oncology Software Market Revenue (USD billion) Forecast, By End User, 2019–2032

Table 08: North America Medical Oncology Software Market Revenue (USD billion) Forecast, By Country, 2019–2032

Table 09: Europe Medical Oncology Software Market Revenue (USD billion) Forecast, By Deployment Type, 2019–2032

Table 10: Europe Medical Oncology Software Market Revenue (USD billion) Forecast, By Application, 2019–2032

Table 11: Europe Medical Oncology Software Market Revenue (USD billion) Forecast, By End User, 2019–2032

Table 12: Europe Medical Oncology Software Market Revenue (USD billion) Forecast, By Country/Sub-Region, 2019–2032

Table 13: Asia Pacific Medical Oncology Software Market Revenue (USD billion) Forecast, By Deployment Type, 2019–2032

Table 14: Asia Pacific Medical Oncology Software Market Revenue (USD billion) Forecast, By Application, 2019–2032

Table 15: Asia Pacific Medical Oncology Software Market Revenue (USD billion) Forecast, By End User, 2019–2032

Table 16: Asia Pacific Medical Oncology Software Market Revenue (USD billion) Forecast, By Country/Sub-Region, 2019–2032

Table 17: Latin America Medical Oncology Software Market Revenue (USD billion) Forecast, By Deployment Type, 2019–2032

Table 18: Latin America Medical Oncology Software Market Revenue (USD billion) Forecast, By Application, 2019–2032

Table 19: Latin America Medical Oncology Software Market Revenue (USD billion) Forecast, By End User, 2019–2032

Table 20: Latin America Medical Oncology Software Market Revenue (USD billion) Forecast, By Country, 2019–2032

Table 21: Middle East & Africa Medical Oncology Software Market Revenue (USD billion) Forecast, By Deployment Type, 2019–2032

Table 22: Middle East & Africa Medical Oncology Software Market Revenue (USD billion) Forecast, By Application, 2019–2032

Table 23: Middle East & Africa Medical Oncology Software Market Revenue (USD billion) Forecast, By End User, 2019–2032

Table 24: Middle East & Africa Medical Oncology Software Market Revenue (USD billion) Forecast, By Country, 2019–2032

STUDY PERIOD: 2019-2032
BASE YEAR:2024
HISTORICAL DATA: 2019-2023
NO OF PAGES: 164

Consulting Services

Healthcare Clients

Related Reports

Get in Touch with Us

US +1 833 909 2966 ( Toll Free )

UK +44 808 502 0280 ( Toll Free )

+91 744 740 1245 (APAC)
sales@fortunebusinessinsights.com